Australian Type 2 Diabetes Risk (AUSDRISK) Assessment Tool

AUSDRISK estimates an adult’s 5‑year risk of developing type 2 diabetes using demographic, lifestyle, and simple anthropometric factors.

Age (years)
25-34035-44+245-54+455-64+6≥ 65+8
Sex
Female0Male+3
Ethnicity
Other0Southern European+2Asian+2Aboriginal/Torres Strait Islander+2Pacific Islander+2
Parental hx of diabetes
No0Yes+3
Hx of high blood pressure
No0Yes+6
Use of antihypertensive medications
No0Yes+2
Current smoker
No0Yes+2
Physical Inactivity
No0Yes+2
BMI
Normal (< 25)0Overweight (25 to <30)+3Obese (30 to < 35)+6Morbidly obese (≥ 35)+8
Waist circumference
Aboriginal/Torres Strait Islander or Asian background > 90 cm (men)0Aboriginal/Torres Strait Islander or Asian background < 80 cm (women)0Southern European, Pacific Islander, or other < 102 cm (men)0Southern European, Pacific Islander, or other < 88 cm (women)0Aboriginal/Torres Strait Islander or Asian background 90-99 cm (men)+4Aboriginal/Torres Strait Islander or Asian background 90-99 cm (women)+4Southern European, Pacific Islander, or other 102-109 cm (men)+4Southern European, Pacific Islander, or other 88-99 cm (women)+4Aboriginal/Torres Strait Islander or Asian background ≥ 100 cm (men)+7Aboriginal/Torres Strait Islander or Asian background ≥ 90 cm (women)+7Southern European, Pacific Islander, or other ≥ 110 cm (men)+7Southern European, Pacific Islander, or other ≥ 100 cm (women)+7

Indications for Use

Used for asymptomatic adults to estimate 5–10‑year risk of developing type 2 diabetes and guide who should receive confirmatory glucose testing or lifestyle‑prevention programs. Identifies individuals with elevated likelihood of impaired fasting glucose or undiagnosed diabetes, but alone screens in a large population proportion, so best used with FPG, OGTT, or HbA1c for high‑risk confirmation (BMJ Open Diabetes Res Care, PPV 28% at high cut‑off 1 [Level II evidence]).

Insights & Cautions

Identifies adults at elevated diabetes risk using simple demographics and lifestyle factors but overestimates or underperforms in some non‑European groups (consistent with wide cross‑ethnic variability in risk score performance 1 [Level II evidence]).
Useful for quick, non‑laboratory triage, yet does not replace diagnostic testing and may miss risk tied to biomarkers.
Be cautious: most diabetes risk models vary across populations and require local validation 2 [Level II evidence].